News

In a Monday morning session entitled "Patient-Reported Outcome Instruments: Overview and Comments on the FDA Guidance," CDER officials stressed the importance of including PROs early in the clinical trial planning process, rather than at data analysis stages. Edwin P. Rock, MD, PhD, medical officer, division of drug oncology products, described the endpoint model/conceptual framework that organizes the amount/type of data for various uses.

i1-334564-1408686893326.jpg

eShowcase

Tools for Clinical Trials Professionals

i1-334578-1408686860301.jpg

A comprehensive list of Web sites that contain trial and registry information for both professionals and potential participants